Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Buy
51
BDSX Quote, Financials, Valuation and Earnings
Last price:
$8.54
Seasonality move
:
-7.16%
Day range:
$7.72 - $8.33
52-week range:
$3.44 - $32.20
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.82x
P/B ratio:
53.43x
Volume:
59.4K
Avg. volume:
227.5K
1-year change:
-70.07%
Market cap:
$65.1M
Revenue:
$71.3M
EPS (TTM):
-$3.93
Analysts' Opinion
-
Consensus RatingBiodesix, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $32.50, Biodesix, Inc. has an estimated upside of 299.26% from its current price of $8.14.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $20.00 representing 100% downside risk from its current price of $8.14.
Fair Value
-
According to the consensus of 5 analysts, Biodesix, Inc. has 299.26% upside to fair value with a price target of $32.50 per share.
BDSX vs. S&P 500
-
Over the past 5 trading days, Biodesix, Inc. has overperformed the S&P 500 by 5.16% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Biodesix, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Biodesix, Inc. has grown year-over-year revenues for 13 quarters straight. In the most recent quarter Biodesix, Inc. reported revenues of $21.8M.
Earnings Growth
-
Biodesix, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Biodesix, Inc. reported earnings per share of -$1.16.
Enterprise value:
121.3M
EV / Invested capital:
1.70x
Price / LTM sales:
7.82x
EV / EBIT:
--
EV / Revenue:
1.51x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-4.14x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$64M
Return On Assets:
-42.55%
Net Income Margin (TTM):
-49.31%
Return On Equity:
-333.87%
Return On Invested Capital:
-50.62%
Operating Margin:
-32.36%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $44M | $65.6M | $80.2M | $18.2M | $21.8M | |
| Gross Profit | $31.1M | $51M | $64M | $14M | $17.7M | |
| Operating Income | -$48.3M | -$34.6M | -$32.3M | -$8.6M | -$7M | |
| EBITDA | -$44M | -$29.2M | -$26.8M | -$7.2M | -$5.7M | |
| Diluted EPS | -$0.90 | -$0.39 | -$3.93 | -$0.07 | -$1.16 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $56.4M | $24.1M | $28.9M | $44M | $33.4M | |
| Total Assets | $90M | $63.2M | $86.8M | $102.7M | $88.7M | |
| Current Liabilities | $22.8M | $37.4M | $32.6M | $13M | $18.2M | |
| Total Liabilities | $74M | $66.1M | $88.2M | $74.9M | $90.4M | |
| Total Equity | $16M | -$2.9M | -$1.4M | $27.9M | -$1.7M | |
| Total Debt | $30M | $22.1M | $49.6M | $61.3M | $71.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$23.4M | -$56M | -$28.2M | -$10.7M | -$8.9M | |
| Cash From Investing | -$22M | -$5.6M | -$1.2M | -$286K | -$67K | |
| Cash From Financing | $50.1M | $73.2M | $14.5M | $145K | $4.8M | |
| Free Cash Flow | -$45.4M | -$61.6M | -$29.3M | -$11M | -$8.9M | |
BDSX
Sector
Market Cap
$65.1M
$28.4M
Price % of 52-Week High
25.28%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
-12.55%
-1.32%
1-Year Price Total Return
-70.07%
-22.19%
Beta (5-Year)
0.625
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$7.73
200-day SMA
Sell
Level
$8.93
Bollinger Bands (100)
Buy
Level
6.83 - 8.57
Chaikin Money Flow
Sell
Level
-15M
20-day SMA
Buy
Level
$7.71
Relative Strength Index (RSI14)
Buy
Level
56.46
ADX Line
Buy
Level
14.44
Williams %R
Sell
Level
-17.8276
50-day SMA
Buy
Level
$7.40
MACD (12, 26)
Buy
Level
0.16
25-day Aroon Oscillator
Buy
Level
8
On Balance Volume
Neutral
Level
15.4M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-4.9392)
Sell
CA Score
(Annual)
Level (-3.4468)
Buy
Beneish M-Score
(Annual)
Level (-40.4435)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (5.0274)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It also offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Louisville, CO.
Stock Forecast FAQ
In the current month, BDSX has received 4 Buy ratings 1 Hold ratings, and 0 Sell ratings. The BDSX average analyst price target in the past 3 months is $32.50.
-
Where Will Biodesix, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Biodesix, Inc. share price will rise to $32.50 per share over the next 12 months.
-
What Do Analysts Say About Biodesix, Inc.?
Analysts are divided on their view about Biodesix, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Biodesix, Inc. is a Sell and believe this share price will drop from its current level to $20.00.
-
What Is Biodesix, Inc.'s Price Target?
The price target for Biodesix, Inc. over the next 1-year time period is forecast to be $32.50 according to 5 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is BDSX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Biodesix, Inc. is a Buy. 4 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of BDSX?
You can purchase shares of Biodesix, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Biodesix, Inc. shares.
-
What Is The Biodesix, Inc. Share Price Today?
Biodesix, Inc. was last trading at $8.54 per share. This represents the most recent stock quote for Biodesix, Inc.. Yesterday, Biodesix, Inc. closed at $8.14 per share.
-
How To Buy Biodesix, Inc. Stock Online?
In order to purchase Biodesix, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get BDSX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BDSX
Sector
P/E ratio
--
23.66x
PEG ratio
0.00x
-0.01x
P/B ratio
53.43x
1.84x
Price / LTM sales
7.82x
1.60x
Growth Metrics
BDSX
Sector
Revenue growth
19.93%
4.85%
Earnings growth
-1557.78%
11.15%
Revenue (5-year growth)
23.77%
6.45%
Earnings forecast
--
-$0.20
Profitability
BDSX
Sector
Profitability FY 2024
$50.4M
$3.6M
Return on invested capital
-50.62%
-30.98%
Return on assets
-42.55%
-27.62%
Return on equity
-333.87%
-36.69%
Earnings Date
Last Earnings Date
Nov
3
Next Earnings Date
Mar
3
Estimated Next Earnings Date
Feb
2
Balance Sheet
BDSX
Sector
Total cash
$16.7M
$27.2M
Short term investments
--
$25.7M
Total assets
$99.2M
$79.9M
Long term debt
$71.5M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
65
Is AAPL Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 38x
Buy
69
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
47
PSTG alert for Dec 4
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
41
SMX alert for Dec 4
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
43
HY alert for Dec 4
Hyster-Yale, Inc. [HY] is up 1.92% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
